Skip to contentBREITMEYER JAMES B — CADENCE PHARMACEUTICALS INC insider: 165 transactions · InsiderLensBREITMEYER JAMES B
- EVP, CMO at CADENCE PHARMACEUTICALS INC · on record since Oct 24, 2006
- Director at NABI BIOPHARMACEUTICALS · on record since May 1, 2026
- VP PHARMACEUTICAL OPERATIONS at APPLIED MOLECULAR EVOLUTION INC · on record since Jan 5, 2004
- Director at ZOGENIX, INC. · on record since Mar 26, 2014
- Director at Otonomy, Inc. · on record since Jun 20, 2018
- Director at GTX INC /DE/ · on record since Jun 20, 2019
- Chief Executive Officer at GTX INC /DE/ · on record since Jun 20, 2019
Insider trading activity of BREITMEYER JAMES B
- Transactions on record
- 165
- since Sep 23, 2003
- Open-market buys
- 4
- $86K
- Open-market sells
- 21
- $1.5M
- Companies traded
- 6
- last filing May 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where BREITMEYER JAMES B has traded
Track record of BREITMEYER JAMES B
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of BREITMEYER JAMES B
Co-insiders of BREITMEYER JAMES B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
DOMAIN ASSOCIATESCADENCE PHARMACEUTICALS INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 1, 2026 | Award | 78,800 | 0.00 USD | $0 | SEC |
| May 1, 2026 | AwardD | 157,400 | 0.00 USD | $0 | SEC |
| Feb 15, 2024 | AwardD | 28,400 | 0.00 USD | $0 | SEC |
| Feb 15, 2024 | AwardD | 6,200 | 0.00 USD | $0 | SEC |
| Jan 5, 2024 | Other | -4,485 | 0.50 USD | $2.2K | SEC |
| Jan 5, 2024 | Other | -50,955 | 0.50 USD | $25.5K | SEC |
| Oct 4, 2023 | AwardD | 100,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -123,750 | — | — | SEC |
| Oct 4, 2023 | OtherD | -637,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 7,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 123,750 | — | — | SEC |
| Oct 4, 2023 | OtherD | -2,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -66,890 | — | — | SEC |
| Oct 4, 2023 | AwardD | 65,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -650,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -100,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 637,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 650,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -65,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 2,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 750,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 22,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -750,000 | — | — | SEC |
| Oct 4, 2023 | OtherD | -7,000 | — | — | SEC |
| Oct 4, 2023 | AwardD | 66,890 | — | — | SEC |